Arch Venture Management’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$216K Buy
22,389
+21,284
+1,926% +$205K 0.07% 11
2025
Q1
$16.1K Sell
1,105
-3,592
-76% -$52.4K 0.01% 9
2024
Q4
$564K Buy
4,697
+3,975
+551% +$477K 0.24% 9
2024
Q3
$135K Hold
722
0.05% 9
2024
Q2
$432K Hold
722
0.16% 9
2024
Q1
$4.43M Buy
+722
New +$4.43M 5.52% 6